![Justin Sun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Justin Sun
Directeur/Membre du Conseil chez
ImmusanT, Inc.
Profil
Justin Sun is currently a Director at Edgemont Pharmaceuticals LLC, a Director at ImmusanT, Inc., a Director at Ekteino Laboratories, Inc., and a Vice President at Oikos Holdings LLC.
He previously worked as a Director at Melinta Subsidiary Corp., an Analyst at Aisling Capital LLC, and an Analyst at Thomas Weisel Partners LLC.
Mr. Sun received his undergraduate degree from Yale University.
Postes actifs de Justin Sun
| Sociétés | Poste | Début |
|---|---|---|
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Directeur/Membre du Conseil | - |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Operates as a holding company that provides financial advisory services | Corporate Officer/Principal | - |
Ekteino Laboratories, Inc.
 Ekteino Laboratories, Inc. BiotechnologyHealth Technology Develops sustained-release drug delivery system for chronic use medications | Directeur/Membre du Conseil | - |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Directeur/Membre du Conseil | 01/01/2014 |
Anciens postes connus de Justin Sun
| Sociétés | Poste | Fin |
|---|---|---|
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Analyste en capital-investissement | 31/12/2009 |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Directeur/Membre du Conseil | - |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Justin Sun
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
Thomas Weisel Partners LLC
Thomas Weisel Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Oikos Holdings LLC
Oikos Holdings LLC Investment ManagersFinance Operates as a holding company that provides financial advisory services | Finance |
ImmusanT, Inc.
ImmusanT, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease | Health Technology |
Ekteino Laboratories, Inc.
Ekteino Laboratories, Inc. BiotechnologyHealth Technology Develops sustained-release drug delivery system for chronic use medications | Health Technology |
